Partners GeneNovate Heidelberg
GeneNovate 2025
GeneNovate is the first nationwide entrepreneurship training program in Germany, designed to empower innovators and entrepreneurs in the field of Gene and Cell Therapies (GCT).
The program targets early-career scientists and physicians, such as advanced students, PhD candidates and Postdocs, but it is also open to experienced researchers and medical professionals.
A key strength of the program lies in its collaborative approach, connecting participants across multiple locations.
The GeneNovate program runs from January to June 2025, includes six full-day workshops and hands-on implementation of new skills through a team project, culminating in a final event.
This comprehensive program is offered free of charge. Travel and accommodation expenses will not be covered by the program.
For more information visit the GeneNovate program website.
You interested to participate? Then apply via the registration page before the registration deadline on 02.12.24.
Workshop series
|
28.01.2025: Workshop 1
|
Introduction to Entrepreneurship | Changing the Healthcare Industry | Creating & Presenting Pitch Desks
|
|
21.02.2025: Workshop 2
|
Value Proposition & Buisness Modell Canvas | IP Protection & Management
|
|
18.03.2025: Workshop 3
|
Analyze your Market | Create your Business Model | Build your Business Case
|
|
01.04.2025: Workshop 4
|
Regulation | Develop your Product/Solution | Go-to-Market: Understand and win customers
|
|
13.05.2025: Workshop 5
|
Legal Foundations for Start-ups | Team management | Project Management | Establish and manage Partnerships
|
|
22.05.2025: Workshop 6
|
Financing and Funding | Investor discussions & Negotiations | Exit options & Strategic value
|
To ensure full commitment to the program, participants are required to attend all 6 full-day workshops. If a participant is unable to attend a workshop, the participant must arrange to attend the same workshop at an alternative site.
Organizer:
Hosts:
Stefan Pfister, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg
Philipp Gebhardt, German Cancer Consortium (DKTK), Heidelberg
